PDF icon PDF herunterladen
Open Access
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2007; 28(04): 23-25
DOI: 10.1055/s-0041-1733238
Selected Summary

Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer (THE TAX 324 trial)

G Prashanth
Department of Medical Oncology, Institute Rotary Cancer Hospital, AIIMS, New Delhi-110029, India
,
Atul Sharma
Department of Medical Oncology, Institute Rotary Cancer Hospital, AIIMS, New Delhi-110029, India
› Institutsangaben
› Weitere Informationen
Auch verfügbar aufeRef
 als PDF herunterladen Lizenzen und Reprints
Preview Container


Publikationsverlauf

Artikel online veröffentlicht:
07. März 2022

© 2007. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30
  • 2 Data from National Cancer registry Programme (ICMR).at: http://www.canceratlasindia.org/ chapter3_5.htm ( accessed on 09.12.07)
  • 3 Mohanti BK, Nachiappan P, Pandey RM, Sharma A, Bahadur S, Thakar A.. Analysis of 2167 head and neck cancer patients’ management, treatment compliance and outcomes from a regional cancer centre, Delhi, India. J Laryngol Otol. 2007;121:49-56
  • 4 Adelstein DJ, LeBlanc M. Does Induction Chemotherapy Have a Role in the Management of Locoregionally Advanced Squamous Cell Head and Neck Cancer?JCO,2006;24:2624-2628
  • 5 Arlene A. Forastiere. Is There a New Role for Induction Chemotherapy in the Treatment of Head and Neck Cancer? JNCI 2004;96(22):1647-1649
  • 6 Pignon JP, Bourhis J, Domenge C, Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three metaanalyses of updated individual data. Lancet 2000;355:949-55.
  • 7 Posner MR, Glisson B, Frenette G, et al. Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the headand neck. J Clin Oncol 2001;19:1096-104.
  • 8 Haddad R, Colevas AD, Tishler R, et al. Docetaxel, cisplatin, and 5-fluorouracilbased induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the DanaFarber Cancer Institute experience.Cancer 2003;97:412-8.
  • 9 Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357:1705- 1715.
  • 10 Vermorken JB, Remenar E, van Herpen C, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007;357:1695- 1704
  • 11 Hitt R, López A, Martínez-Trufero J, et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 2005;23:8636-8645. [Erratum, J Clin Oncol 2006;24:1015.]
  • 12 Calais G, Pointreau Y, Alfonsi M et al. Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer. Preliminary results of GORTEC 2000–01. J Clin Oncol 2006;24:281s.
  • 13 Posner M. Evolving Strategies for Combined- Modality Therapy for Locally Advanced Head and Neck Cancer.The Oncologist 2007;12:967-974